ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Universal Sequencing Technology Corporation Launches High-Throughput Solution For Microbial WGS Library Preparation

By: PRLog

CARLSBAD, Calif. - March 14, 2023 - PRLog -- Universal Sequencing Technology Corporation (UST), a global leader in genomic sequencing innovations, announced today the release of a high throughput microbial WGS library preparation kit enabling 2nd-generation short-read sequencers to produce long-range results in a much affordable price for microbial genomes.

With this special high throughput kit, users can pool more microbial samples in one sequencing run in combination with our 96-well plate multiplexing primers, which includes 10-base indexes and significantly reduces NGS library preparation and sequencing costs.

Researchers will now be able to take advantage of the ultra-long linked-read results to provide unparalleled genomic information with up to 200Kb gDNA fragments for microbial genome analyses.

With TELL-Seq technology, we've made NGS library preparation easy. Our products effectively improve performance, process time, and budget across a broad range of sample types with a proven track record.

Dr. Tom Chen, Chief Scientific Officer of UST, stated, "We are further streamlining the TELL-seq workflow with reduced cost per reaction and expanded throughput in response to increased customer demands."

UST's TELL-Seq is a patent-pending transposase-based linked-read library preparation technology that enables short-read 2nd generation DNA sequencing platforms, such as Illumina sequencers, to produce long-range sequencing results (averaging linked-read molecule length greater than 40kb and up to 200kb). With a simple workflow, a sequencing-ready Illumina library can be prepared in PCR tubes in about 3 hours, cost-effective and no special lab equipment needed.

ABOUT UST

Universal Sequencing Technology Corporation (UST), a Boston and San Diego-based NGS biotechnology company, was established by a group of NGS veterans. UST is dedicated to developing the most advanced DNA sequencing technologies and has filed more than 20 PCT patent applications covering linked read NGS library preparation, single-cell sequencing, and groundbreaking 3rd-generation DNA sequencing technologies. UST is poised to lead the next wave of DNA sequencing innovations.

www.universalsequencing.com

Contact
Ru Zheng
***@universalsequencing.com

Photos: (Click photo to enlarge)

Universal Sequencing Technology Corporation Logo

Read Full Story - Universal Sequencing Technology Corporation Launches High-Throughput Solution For Microbial WGS Library Preparation | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.